Citations (96)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Yamaç Tekintaş & Aybala Temel. (2024) Antisense oligonucleotides: a promising therapeutic option against infectious diseases. Nucleosides, Nucleotides & Nucleic Acids 43:1, pages 1-39.
Read now
Read now
David Ulkoski, Annette Bak, John T. Wilson & Venkata R. Krishnamurthy. (2019) Recent advances in polymeric materials for the delivery of RNA therapeutics. Expert Opinion on Drug Delivery 16:11, pages 1149-1167.
Read now
Read now
Kevin Craig, Marc Abrams & Mansoor Amiji. (2018) Recent preclinical and clinical advances in oligonucleotide conjugates. Expert Opinion on Drug Delivery 15:6, pages 629-640.
Read now
Read now
Yosuke Takahashi, Yuki Araie, Daiki Nomura, Yuki Takahashi, Kohei Sano, Hideo Saji, Yoshinobu Takakura & Makiya Nishikawa. (2018) Construction of nanostructured DNA harbouring phosphorodiamidate morpholino oligonucleotide for controlled tissue distribution in mice. Journal of Drug Targeting 26:4, pages 373-381.
Read now
Read now
Susan Jarmin, Hanna Kymalainen, Linda Popplewell & George Dickson. (2014) New developments in the use of gene therapy to treat Duchenne muscular dystrophy. Expert Opinion on Biological Therapy 14:2, pages 209-230.
Read now
Read now
Articles from other publishers (91)
Nupur Angrish & Garima Khare. (2023) Antisense oligonucleotide based therapeutics and its applications against bacterial infections. Medicine in Drug Discovery 20, pages 100166.
Crossref
Crossref
Shunji Imai, Yusuke Suda, Jumpei Mori, Yoshihiro Sasaki, Tetsuhiro Yamada & Kazutomi Kusano. (2023) Prediction of Human Pharmacokinetics of Phosphorodiamidate Morpholino Oligonucleotides in Duchenne Muscular Dystrophy Patients Using Viltolarsen. Drug Metabolism and Disposition 51:10, pages 1428-1435.
Crossref
Crossref
Priyanka Mangla, Quentin Vicentini & Annabelle Biscans. (2023) Therapeutic Oligonucleotides: An Outlook on Chemical Strategies to Improve Endosomal Trafficking. Cells 12:18, pages 2253.
Crossref
Crossref
Rongrong Jiang, Shirin Hooshfar, Marsha Rebecca Eno, Cassandra Yun, Estevan Sonego Zimmermann & Raku Shinkyo. (2023) Factors Influencing ADME Properties of Therapeutic Antisense Oligonucleotides:
Physicochemical Characteristics and Beyond. Current Drug Metabolism 24:7, pages 536-552.
Crossref
Crossref
Raghav Gupta, Sagar Salave, Dhwani Rana, Bharathi Karunakaran, Arun Butreddy, Derajram Benival & Nagavendra Kommineni. (2023) Versatility of Liposomes for Antisense Oligonucleotide Delivery: A Special Focus on Various Therapeutic Areas. Pharmaceutics 15:5, pages 1435.
Crossref
Crossref
Sau Har Lee, Chu Xin Ng, Sharon Rachel Wong & Pei Pei Chong. (2023) MiRNAs Overexpression and Their Role in Breast Cancer: Implications
for Cancer Therapeutics. Current Drug Targets 24:6, pages 484-508.
Crossref
Crossref
Hideo TakakusaNorihiko IwazakiMakiya Nishikawa, Tokuyuki YoshidaSatoshi Obika & Takao Inoue. (2023) Drug Metabolism and Pharmacokinetics of Antisense Oligonucleotide Therapeutics: Typical Profiles, Evaluation Approaches, and Points to Consider Compared with Small Molecule Drugs. Nucleic Acid Therapeutics 33:2, pages 83-94.
Crossref
Crossref
Seong Jun Jo, Soon Uk Chae, Chae Bin Lee & Soo Kyung Bae. (2023) Clinical Pharmacokinetics of Approved RNA Therapeutics. International Journal of Molecular Sciences 24:1, pages 746.
Crossref
Crossref
Johnsi Mathivanan, Zhixue Bai, Alan Chen & Jia Sheng. (2022) Design, Synthesis, and Characterization of a Novel 2′–5′-Linked Amikacin-Binding Aptamer: An Experimental and MD Simulation Study. ACS Chemical Biology 17:12, pages 3478-3488.
Crossref
Crossref
Bao T. Le, Sibasish Paul, Katarzyna Jastrzebska, Heera Langer, Marvin H. Caruthers & Rakesh N. Veedu. (2022) Thiomorpholino oligonucleotides as a robust class of next generation platforms for alternate mRNA splicing. Proceedings of the National Academy of Sciences 119:36.
Crossref
Crossref
Yiran Zhu, Liyuan Zhu, Xian Wang & Hongchuan Jin. (2022) RNA-based therapeutics: an overview and prospectus. Cell Death & Disease 13:7.
Crossref
Crossref
Thomas A. Forbes, Bob D. Brown & Chengjung Lai. (2021) Therapeutic RNA interference: A novel approach to the treatment of primary hyperoxaluria. British Journal of Clinical Pharmacology 88:6, pages 2525-2538.
Crossref
Crossref
Maxim S. Kupryushkin, Anton V. Filatov, Nadezhda L. Mironova, Olga A. Patutina, Ivan V. Chernikov, Elena L. Chernolovskaya, Marina A. Zenkova, Dmitrii V. Pyshnyi, Dmitry A. Stetsenko, Sidney Altman & Valentin V. Vlassov. (2022) Antisense oligonucleotide gapmers containing phosphoryl guanidine groups reverse MDR1-mediated multiple drug resistance of tumor cells. Molecular Therapy - Nucleic Acids 27, pages 211-226.
Crossref
Crossref
Lars Weidolf, Anders Björkbom, Anders Dahlén, Marie Elebring, Peter Gennemark, Mikko Hölttä, David Janzén, XueQing Li & Shalini Andersson. (2021) Distribution and biotransformation of therapeutic antisense oligonucleotides and conjugates. Drug Discovery Today 26:10, pages 2244-2258.
Crossref
Crossref
Seyed Mohammad Gheibi‐Hayat & Khadijeh Jamialahmadi. (2020) Antisense Oligonucleotide (AS‐ODN) Technology: Principle, Mechanism and Challenges. Biotechnology and Applied Biochemistry 68:5, pages 1086-1094.
Crossref
Crossref
Kentaro Ito, Hideo Takakusa, Masayo Kakuta, Akira Kanda, Nana Takagi, Hiroyuki Nagase, Nobuaki Watanabe, Daigo Asano, Ryoya Goda, Takeshi Masuda, Akifumi Nakamura, Yoshiyuki Onishi, Toshio Onoda, Makoto Koizumi, Yasuhiro Takeshima, Masafumi Matsuo & Kiyosumi Takaishi. (2021) Renadirsen, a Novel 2′OMeRNA/ENA® Chimera Antisense Oligonucleotide, Induces Robust Exon 45 Skipping for Dystrophin In Vivo. Current Issues in Molecular Biology 43:3, pages 1267-1281.
Crossref
Crossref
Hisham Kashif, Dilan Shah & Sangeetha Sukumari-Ramesh. (2021) Dysregulation of microRNA and Intracerebral Hemorrhage: Roles in Neuroinflammation. International Journal of Molecular Sciences 22:15, pages 8115.
Crossref
Crossref
Christopher L. Barkau, Daniel O'Reilly, Seth B. Eddington, Masad J. Damha & Keith T. Gagnon. (2021) Small nucleic acids and the path to the clinic for anti-CRISPR. Biochemical Pharmacology 189, pages 114492.
Crossref
Crossref
Monique C. P. Mendonça, Ayse Kont, Maria Rodriguez Aburto, John F. Cryan & Caitriona M. O’Driscoll. (2021) Advances in the Design of (Nano)Formulations for Delivery of Antisense Oligonucleotides and Small Interfering RNA: Focus on the Central Nervous System. Molecular Pharmaceutics 18:4, pages 1491-1506.
Crossref
Crossref
Mohadeseh Dastpeyman, Ramin Sharifi, Azin Amin, John A. Karas, Brittany Cuic, Yijun Pan, Joseph A. Nicolazzo, Bradley J. Turner & Fazel Shabanpoor. (2021) Endosomal escape cell-penetrating peptides significantly enhance pharmacological effectiveness and CNS activity of systemically administered antisense oligonucleotides. International Journal of Pharmaceutics 599, pages 120398.
Crossref
Crossref
Hossein Ghanbarian, Shahin Aghamiri, Mohamad Eftekhary, Nicole Wagner & Kay-Dietrich Wagner. (2021) Small Activating RNAs: Towards the Development of New Therapeutic Agents and Clinical Treatments. Cells 10:3, pages 591.
Crossref
Crossref
Alex J. Anderson, Emerson Grey, Nicholas J. Bongiardina, Christopher N. Bowman & Stephanie J. Bryant. (2021) Synthesis and Characterization of Click Nucleic Acid Conjugated Polymeric Microparticles for DNA Delivery Applications. Biomacromolecules 22:3, pages 1127-1136.
Crossref
Crossref
Aapo Aho, Antti Äärelä, Heidi Korhonen & Pasi Virta. (2021) Expanding the Scope of the Cleavable N-(Methoxy)oxazolidine Linker for the Synthesis of Oligonucleotide Conjugates. Molecules 26:2, pages 490.
Crossref
Crossref
Benjamin I. Andrews, Firoz D. Antia, Shawn B. Brueggemeier, Louis J. Diorazio, Stefan G. Koenig, Michael E. Kopach, Heewon Lee, Martin Olbrich & Anna L. Watson. (2020) Sustainability Challenges and Opportunities in Oligonucleotide Manufacturing. The Journal of Organic Chemistry 86:1, pages 49-61.
Crossref
Crossref
Shusuke Toden, Timothy J. Zumwalt & Ajay Goel. (2021) Non-coding RNAs and potential therapeutic targeting in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1875:1, pages 188491.
Crossref
Crossref
Johannes Winkler. 2021. Epigenetics in Cardiovascular Disease. Epigenetics in Cardiovascular Disease
349
373
.
Prabhjeet Singh, Aditi Singh, Shruti Shah, Jalpa Vataliya, Anupama Mittal & Deepak Chitkara. (2020) RNA Interference Nanotherapeutics for Treatment of Glioblastoma Multiforme. Molecular Pharmaceutics 17:11, pages 4040-4066.
Crossref
Crossref
Anna Kilanowska, Łukasz Nuckowski & Sylwia Studzińska. (2020) Studying in vitro metabolism of the first and second generation of antisense oligonucleotides with the use of ultra-high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. Analytical and Bioanalytical Chemistry 412:27, pages 7453-7467.
Crossref
Crossref
K. M. Taufiqul Arif, Esther K. Elliott, Larisa M. Haupt & Lyn R. Griffiths. (2020) Regulatory Mechanisms of Epigenetic miRNA Relationships in Human Cancer and Potential as Therapeutic Targets. Cancers 12:10, pages 2922.
Crossref
Crossref
Andreas Spannbauer, Julia Mester-Tonczar, Denise Traxler, Nina Kastner, Katrin Zlabinger, Ena Hašimbegović, Martin Riesenhuber, Noemi Pavo, Georg Goliasch & Mariann Gyöngyösi. (2020) Large Animal Models of Cell-Free Cardiac Regeneration. Biomolecules 10:10, pages 1392.
Crossref
Crossref
Anna Kilanowska & Sylwia Studzińska. (2020)
In vivo
and
in vitro
studies of antisense oligonucleotides – a review
. RSC Advances 10:57, pages 34501-34516.
Crossref
Crossref
Wenzhan Yang, Prajakta Gadgil, Venkata R. Krishnamurthy, Margaret Landis, Pankajini Mallick, Dipal Patel, Phenil J. Patel, Darren L. Reid & Manuel Sanchez-Felix. (2020) The Evolving Druggability and Developability Space: Chemically Modified New Modalities and Emerging Small Molecules. The AAPS Journal 22:2.
Crossref
Crossref
Yuhua Weng, Qianqian Huang, Chunhui Li, Yongfeng Yang, Xiaoxia Wang, Jie Yu, Yuanyu Huang & Xing-Jie Liang. (2020) Improved Nucleic Acid Therapy with Advanced Nanoscale Biotechnology. Molecular Therapy - Nucleic Acids 19, pages 581-601.
Crossref
Crossref
Alexander Batista-Duharte, Luis Sendra, Maria Herrero, Damiana Téllez-Martínez, Iracilda Carlos & Salvador Aliño. (2020) Progress in the Use of Antisense Oligonucleotides for Vaccine Improvement. Biomolecules 10:2, pages 316.
Crossref
Crossref
Anna R. Stasińska, Piotr Putaj & Marcin K. Chmielewski. (2020) Disulfide bridge as a linker in nucleic acids’ bioconjugation. Part II: A summary of practical applications. Bioorganic Chemistry 95, pages 103518.
Crossref
Crossref
Sara Karaki, Clément Paris & Palma Rocchi. 2019. Antisense Therapy. Antisense Therapy.
Jing Li, Ju Liu, Jennifer Enders, Michael Arciprete, Chris Tran, Krishna Aluri, Li-Hua Guan, Jonathan O'Shea, Anna Bisbe, Klaus Charissé, Ivan Zlatev, Diana Najarian & Yuanxin Xu. (2019)
Discovery of a novel deaminated metabolite of a single-stranded oligonucleotide
in vivo
by mass spectrometry
. Bioanalysis 11:21, pages 1955-1965.
Crossref
Crossref
A. V. Markov, M. S. Kupryushkin, E. P. Goncharova, R. N. Amirkhanov, S. V. Vasilyeva, D. V. Pyshnyi, M. A. Zenkova & E. B. Logashenko. (2020) Antiviral Activity of a New Class of Chemically Modified Antisense Oligonucleotides against Influenza А Virus. Russian Journal of Bioorganic Chemistry 45:6, pages 774-782.
Crossref
Crossref
Vasile Simulescu & Gheorghe Ilia. (2019) Solid-phase Synthesis of Phosphorus Derivatives. Current Organic Chemistry 23:6, pages 679-688.
Crossref
Crossref
Rintaro Iwata Hara, Tatsuya Saito, Tomoki Kogure, Yuka Hamamura, Naoki Uchiyama, Yohei Nukaga, Naoki Iwamoto & Takeshi Wada. (2019) Stereocontrolled Synthesis of Boranophosphate DNA by an Oxazaphospholidine Approach and Evaluation of Its Properties. The Journal of Organic Chemistry 84:12, pages 7971-7983.
Crossref
Crossref
Wanyi Tai. (2019) Current Aspects of siRNA Bioconjugate for In Vitro and In Vivo Delivery. Molecules 24:12, pages 2211.
Crossref
Crossref
Rajen Kundu. (2019) Borane phosphonate DNA: a versatile unnatural internucleotide linkage. New Journal of Chemistry 43:11, pages 4323-4328.
Crossref
Crossref
Shouta Miyatake, Yoshitaka Mizobe, Maria K. Tsoumpra, Kenji Rowel Q. Lim, Yuko Hara, Fazel Shabanpoor, Toshifumi Yokota, Shin’ichi Takeda & Yoshitsugu Aoki. (2019) Scavenger Receptor Class A1 Mediates Uptake of Morpholino Antisense Oligonucleotide into Dystrophic Skeletal Muscle. Molecular Therapy - Nucleic Acids 14, pages 520-535.
Crossref
Crossref
Patrik Andersson & Cathaline den Besten. 2019. Advances in Nucleic Acid Therapeutics. Advances in Nucleic Acid Therapeutics
474
531
.
C.I. Edvard Smith & Rula Zain. (2019) Therapeutic Oligonucleotides: State of the Art. Annual Review of Pharmacology and Toxicology 59:1, pages 605-630.
Crossref
Crossref
Raymond M. Schiffelers, Erik Oude Blenke & Enrico Mastrobattista. 2019. Pharmaceutical Biotechnology. Pharmaceutical Biotechnology
305
322
.
Cornelia Lorenzer & Johannes Winkler. 2019. Nanotechnology for Nucleic Acid Delivery. Nanotechnology for Nucleic Acid Delivery
61
72
.
Xiao-Yang He, Jing Wang, Dan-Dan Lu & Sheng-Qi Wang. (2018) Synthesis and Antisense Properties of 2′β-F-Arabinouridine Modified Oligonucleotides with 4′-C-OMe Substituent. Molecules 23:9, pages 2374.
Crossref
Crossref
Mehrdad Dirin & Johannes Winkler. 2018. Oligonucleotide‐Based Drugs and Therapeutics. Oligonucleotide‐Based Drugs and Therapeutics
137
160
.
Helen Lightfoot, Anneliese Schneider & Jonathan Hall. 2018. Oligonucleotide‐Based Drugs and Therapeutics. Oligonucleotide‐Based Drugs and Therapeutics
107
136
.
Johannes Winkler. (2018) Extrahepatic Targeting of Oligonucleotides with Receptor-Binding Non-Immunoglobulin Scaffold Proteins. Nucleic Acid Therapeutics 28:3, pages 137-145.
Crossref
Crossref
Phuc V. Pham. 2018. Omics Technologies and Bio-Engineering. Omics Technologies and Bio-Engineering
449
469
.
Yohei Nukaga & Takeshi Wada. 2018. Synthesis of Therapeutic Oligonucleotides. Synthesis of Therapeutic Oligonucleotides
271
284
.
Karima Relizani, Graziella Griffith, Lucía Echevarría, Faouzi Zarrouki, Patricia Facchinetti, Cyrille Vaillend, Christian Leumann, Luis Garcia & Aurélie Goyenvalle. (2017) Efficacy and Safety Profile of Tricyclo-DNA Antisense Oligonucleotides in Duchenne Muscular Dystrophy Mouse Model. Molecular Therapy - Nucleic Acids 8, pages 144-157.
Crossref
Crossref
Eric Valeur, Stéphanie M. Guéret, Hélène Adihou, Ranganath Gopalakrishnan, Malin Lemurell, Herbert Waldmann, Tom N. Grossmann & Alleyn T. Plowright. (2017) New Modalities for Challenging Targets in Drug Discovery. Angewandte Chemie International Edition 56:35, pages 10294-10323.
Crossref
Crossref
Eric Valeur, Stéphanie M. Guéret, Hélène Adihou, Ranganath Gopalakrishnan, Malin Lemurell, Herbert Waldmann, Tom N. Grossmann & Alleyn T. Plowright. (2017) Neue Modalitäten für schwierige Zielstrukturen in der Wirkstoffentwicklung. Angewandte Chemie 129:35, pages 10428-10459.
Crossref
Crossref
Juozas Baltusnikas, Andrej Fokin, Johannes Winkler & Julius Liobikas. (2017) Long-term regulation of gene expression in muscle cells by systemically delivered siRNA. Journal of Controlled Release 256, pages 101-113.
Crossref
Crossref
Antonia Geyer, Cornelia Lorenzer, Sebastian Gehrig, Manuela Simlinger, Johannes Winkler, Haider Sami & Manfred Ogris. (2017) Fluorescence- and computed tomography for assessing the biodistribution of siRNA after intratracheal application in mice. International Journal of Pharmaceutics 525:2, pages 359-366.
Crossref
Crossref
Steven F Dowdy. (2017) Overcoming cellular barriers for RNA therapeutics. Nature Biotechnology 35:3, pages 222-229.
Crossref
Crossref
Sterghios A. Moschos, Louise Usher & Mark A. Lindsay. (2017) Clinical potential of oligonucleotide-based therapeutics in the respiratory system. Pharmacology & Therapeutics 169, pages 83-103.
Crossref
Crossref
David B. Rozema. 2017. Platform Technologies in Drug Discovery and Validation. Platform Technologies in Drug Discovery and Validation
17
59
.
Danielle C. Arruda, Céline Hoffmann, Christine Charrueau, Pascal Bigey & Virginie Escriou. 2017. Nanostructures for Novel Therapy. Nanostructures for Novel Therapy
713
740
.
Michela Alessandra Denti & Giuseppina Covello. 2017. Safety and Efficacy of Gene-Based Therapeutics for Inherited Disorders. Safety and Efficacy of Gene-Based Therapeutics for Inherited Disorders
191
217
.
Chengjung Lai, Cristina Martin-Higueras & Eduardo Salido. 2017. Safety and Efficacy of Gene-Based Therapeutics for Inherited Disorders. Safety and Efficacy of Gene-Based Therapeutics for Inherited Disorders
159
190
.
Volker Baumann, Cornelia Lorenzer, Michael Thell, Anna-Maria Winkler & Johannes Winkler. 2017. Functional Genomics. Functional Genomics
351
360
.
Mehrdad Dirin, Ernst Urban, Christian R. Noe & Johannes Winkler. (2016) Fragment-based solid-phase assembly of oligonucleotide conjugates with peptide and polyethylene glycol ligands. European Journal of Medicinal Chemistry 121, pages 132-142.
Crossref
Crossref
Rudolph L. Juliano. (2016) The delivery of therapeutic oligonucleotides. Nucleic Acids Research 44:14, pages 6518-6548.
Crossref
Crossref
Elena Moroz, Simon Matoori & Jean-Christophe Leroux. (2016) Oral delivery of macromolecular drugs: Where we are after almost 100 years of attempts. Advanced Drug Delivery Reviews 101, pages 108-121.
Crossref
Crossref
Yohei Nukaga, Natsuhisa Oka & Takeshi Wada. (2016) Stereocontrolled Solid-Phase Synthesis of Phosphate/Phosphorothioate (PO/PS) Chimeric Oligodeoxyribonucleotides on an Automated Synthesizer Using an Oxazaphospholidine–Phosphoramidite Method. The Journal of Organic Chemistry 81:7, pages 2753-2762.
Crossref
Crossref
Bita Sedaghati, Jan Hoyer, Achim Aigner, Michael C. Hacker & Michaela Schulz-Siegmund. 2016. Regenerative Medicine - from Protocol to Patient. Regenerative Medicine - from Protocol to Patient
185
210
.
Barbara Nawrot, Olga Michalak, Barbara Mikołajczyk & Wojciech J. Stec. (2015) Acyclic analogs of nucleosides based on tris(hydroxymethyl)phosphine oxide: synthesis and incorporation into short DNA oligomers. Heterocyclic Communications 21:5, pages 303-314.
Crossref
Crossref
Johannes Winkler. (2015) Therapeutic oligonucleotides with polyethylene glycol modifications. Future Medicinal Chemistry 7:13, pages 1721-1731.
Crossref
Crossref
Mehrdad Dirin, Ernst Urban, Bodo Lachmann, Christian R Noe & Johannes Winkler. (2015) Concise postsynthetic preparation of oligonucleotide–oligopeptide conjugates through facile disulfide bond formation. Future Medicinal Chemistry 7:13, pages 1657-1673.
Crossref
Crossref
Cornelia Lorenzer, Mehrdad Dirin, Anna-Maria Winkler, Volker Baumann & Johannes Winkler. (2015) Going beyond the liver: Progress and challenges of targeted delivery of siRNA therapeutics. Journal of Controlled Release 203, pages 1-15.
Crossref
Crossref
M. I. Zvereva, T. S. Zatsepin, D. M. Azhibek, O. S. Shubernetskaya, O. V. Shpanchenko & O. A. Dontsova. (2015) Oligonucleotide inhibitors of telomerase: Prospects for anticancer therapy and diagnostics. Biochemistry (Moscow) 80:3, pages 251-259.
Crossref
Crossref
Yohei Nukaga, Tetsuhiko Takemura, Naoki Iwamoto, Natsuhisa Oka & Takeshi Wada. (2015) Enhancement of the affinity of 2′-O-Me-oligonucleotides for complementary RNA by incorporating a stereoregulated boranophosphate backbone. RSC Advances 5:4, pages 2392-2395.
Crossref
Crossref
D. Marson, E. Laurini, P. PosoccoM. Fermeglia & S. Pricl. (2015) Cationic carbosilane dendrimers and oligonucleotide binding: an energetic affair. Nanoscale 7:9, pages 3876-3887.
Crossref
Crossref
Aiping Zhang, Kitipong Uaesoontrachoon, Conner Shaughnessy, Jharna R. Das, Sree Rayavarapu, Kristy J. Brown, Patricio E. Ray, Kanneboyina Nagaraju, John N. van den Anker, Eric P. Hoffman & Yetrib Hathout. (2015) The use of urinary and kidney SILAM proteomics to monitor kidney response to high dose morpholino oligonucleotides in the mdx mouse. Toxicology Reports 2, pages 838-849.
Crossref
Crossref
Nasrin Shokrzadeh, Anna-Maria Winkler, Mehrdad Dirin & Johannes Winkler. (2014) Oligonucleotides conjugated with short chemically defined polyethylene glycol chains are efficient antisense agents. Bioorganic & Medicinal Chemistry Letters 24:24, pages 5758-5761.
Crossref
Crossref
Jing Li, Xingyu Wang & Xingguo Liang. (2014) Modification of Nucleic Acids by Azobenzene Derivatives and Their Applications in Biotechnology and Nanotechnology. Chemistry – An Asian Journal 9:12, pages 3344-3358.
Crossref
Crossref
Volker Baumann & Johannes Winkler. (2014) miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents. Future Medicinal Chemistry 6:17, pages 1967-1984.
Crossref
Crossref
Pedro M. D. Moreno & Ana P. Pêgo. (2014) Therapeutic antisense oligonucleotides against cancer: hurdling to the clinic. Frontiers in Chemistry 2.
Crossref
Crossref
Edward J. Wild & Sarah J. Tabrizi. (2014) Targets for future clinical trials in Huntington's disease: What's in the pipeline?. Movement Disorders 29:11, pages 1434-1445.
Crossref
Crossref
A. Fiszer & W. J. Krzyzosiak. (2014) Oligonucleotide-based strategies to combat polyglutamine diseases. Nucleic Acids Research 42:11, pages 6787-6810.
Crossref
Crossref
Babak Basiri & Michael G Bartlett. (2014) LC–MS of oligonucleotides: applications in biomedical research. Bioanalysis 6:11, pages 1525-1542.
Crossref
Crossref
Zuzana Gaziova, Volker Baumann, Anna-Maria Winkler & Johannes Winkler. (2014) Chemically defined polyethylene glycol siRNA conjugates with enhanced gene silencing effect. Bioorganic & Medicinal Chemistry 22:7, pages 2320-2326.
Crossref
Crossref
Jin Huk Choi & Maria A. Croyle. (2013) Emerging Targets and Novel Approaches to Ebola Virus Prophylaxis and Treatment. BioDrugs 27:6, pages 565-583.
Crossref
Crossref
Jonathan P WongJohannes Winkler. 2013. Nucleic Acid-Based Drugs. Nucleic Acid-Based Drugs
132
139
.
Jonathan P WongJohannes Winkler. 2013. Nucleic Acid-Based Drugs. Nucleic Acid-Based Drugs
36
53
.
Johannes Winkler. (2013) Oligonucleotide conjugates for therapeutic applications. Therapeutic Delivery 4:7, pages 791-809.
Crossref
Crossref
Claes Wahlestedt. (2013) Targeting long non-coding RNA to therapeutically upregulate gene expression. Nature Reviews Drug Discovery 12:6, pages 433-446.
Crossref
Crossref